Hjem › Metastatisk kreft › Colorado › Aurora
Kliniske studier for Metastatisk kreft i Aurora, CO
25 studier for Metastatisk kreft søker deltakere på steder i og rundt Aurora (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Aurora
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- UCHealth University of Colorado Hospital, Aurora
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekruttererFase 1
- University of Colorado Anschutz Medical Campus, Aurora
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Aurora
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- University of Colorado Cancer Center, Aurora
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruttererFase 1/2
- Rocky Mountain Cancer Centers,LLP, Aurora
- Clinical and Translational Research Center(CTRC), Aurora
- University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
- og 2 flere
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- University of Colorado Health Hospital, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- University of Colorado, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- University of Colorado, Aurora
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RekruttererFase 1/2
- Crinetics Study Site, Aurora
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekruttererFase 1
- University of Colorado - Aurora Cancer Center, Aurora
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- University of Colorado Cancer Center, Aurora
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekruttererFase 1/2
- University of Colorado Cancer Center, Aurora
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RekruttererFase 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RekruttererFase 1/2
- University of Colorado Cancer Center, Aurora
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruttererFase 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
Venetoclax Basket Trial for High Risk Hematologic Malignancies
RekruttererFase 1
- Children's Hospital Colorado, Aurora
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- UCHealth Cancer Care - Anschutz Medical Campus, Aurora
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
RekruttererFase 3
- University of Colorado Cancer Center, Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
RekruttererFase 1
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- University of Colorado School of Medicine, Aurora
Metastatisk kreft-studier i andre byer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andre studier i Aurora
- Kreft (alle typer)35 studier
- Kolorektal kreft32 studier
- Ikke-småcellet lungekreft31 studier
- Brystkreft28 studier
- Eggstokkreft25 studier
- Type 1-diabetes23 studier
- Fedme22 studier
- Prostatakreft19 studier
- Lungekreft19 studier
- Hjertesvikt18 studier
- Melanom18 studier
- Akut myelogen leukemi16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.